Korean J Pathol.
1999 Aug;33(8):589-595.
Expressions of p53 and MIB-1 in Glandular Lesions of the Uterine Cervix
- Affiliations
-
- 1Department of Pathology, College of Medicine, Pusan National University, Korea.
- 2 Department of Pathology, Pusan Paik Hospital, College of Medicine, Inje University, Pusan 614-735, Korea.
Abstract
-
The glandular lesions of the uterine cervix can be classified into endocervical
glandular dysplasia (EGD), adenocarcinoma in situ (AIS) and adenocarcinoma, but the
diagnostic criteria and the continuity of endocervical glandular lesions are still
controversial. The aim of this study was to evaluate the significance of
immunohistochemical findings of p53 and MIB-1 in the discrimination and the continuity
of EGD, AIS and adenocarcinoma. The materials for the study included 11 cases of
adenocarcinoma, 7 cases of AIS, 12 cases of high grade EGD, and 19 cases of low grade
EGD. Also included were eleven benign glandular lesions (5 cases of tuboendometrial
metaplasia, 3 cases of mesonephric remnant, 3 cases of microglandular hyperplasia). A
strong reaction of more than 5% of the glandular epithelial nuclei was interpreted as
positive for p53 protein. MIB-1 expression was analyzed semiquantitatively as negative, 1
, 2 , 3 , depending on the percentage of positive nuclei (less than 1%, 1~9%, 10~39%, > or = 40%, respectively). p53 protein expression was found in 3 (27.3%) out of 11
cases of adenocarcinoma, and 2 (28.6%) out of 7 cases of AIS. But all of high and low
grade EGD cases were negative. High MIB-1 labelling index (> or =10%) was found in all
adenocarcinoma cases and in 3 (42.9%) out of 7 cases of AIS. But only 2 (17.7%) out of
12 cases of high grade EGD showed high MIB-1 labelling index, and all of low grade
EGD and benign lesions showed negligible MIB-1 positivities. In summary, MIB-1
labelling index might be valuable in the discrimination of malignant glandular lesions and
endocervical glandular dysplasia from benign lesions, but p53 expression could be a
useful parameter in the discrimination of malignant glandular lesions from endocervical
glandular dysplasia and benign lesions.